Nanobiotix Analyst Price Targets - Benzinga

Nanobiotix SA

NBTXNASDAQ

Trade with Public

Trade with Public

$25.75

-2.15-7.71%

마지막 업데이트: Oct 2, 8:44 AM

$27.80

-0.1-0.36%

개요 뉴스 실적 전망 이벤트목표가재무 심리 비교 주식 보고서

Nanobiotix Analyst Price Targets - Benzinga

Nanobiotix Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nanobiotix (NBTX).

Price Target Range — 6 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$44Upside to Avg. PT+58.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	Guggenheim	Paul Jeng	Assumes	Buy	$64
Jun 4, 2026	Leerink Partners	Jonathan Chang	PT Raise	Outperform	$37→$46
May 1, 2026	UBS	Colin Bristow	PT Raise	Neutral	$4→$30
Apr 2, 2026	Guggenheim	Michael Schmidt	PT Raise	Buy	$26→$36
Feb 6, 2026	Guggenheim	Michael Schmidt	PT Raise	Buy	$8→$26
Apr 4, 2025	Guggenheim	Michael Schmidt	PT Cut	Buy	$12→$8
Aug 28, 2024	Guggenheim	Michael Schmidt	Initiate	Buy	$12
Dec 8, 2023	Leerink Partners	Jonathan Chang	Initiate	Outperform	$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Assumes Nanobiotix at Buy, Announces Price Target of $64

Guggenheim analyst Paul Jeng assumes Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $64.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on Nanobiotix, Raises Price Target to $46

Leerink Partners analyst Jonathan Chang maintains Nanobiotix (NASDAQ:NBTX) with a Outperform and raises the price target from $37 to $46.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $26 to $36.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and lowers the price target from $12 to $8.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Nanobiotix with Buy Rating, Announces Price Target of $12

Guggenheim analyst Michael Schmidt initiates coverage on Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk